Search research articles
Contact Us
Filters
Showing results (171-180 of 652) with videos related to
Page
of 66
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
May 8, 2010
Shorter preoperative fibrin clot lysis time predisposes to higher chest tube drainage in patients undergoing elective coronary artery bypass grafting surgery
Anetta Undas, Ewa Wypasek, Bogusław Kapelak, et al.
Cardiovascular Diabetology
|
May 1, 2015
Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
Grzegorz Gajos, Malgorzata Konieczynska, Jaroslaw Zalewski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 19, 2004
Purification of antibodies against N-homocysteinylated proteins by affinity chromatography on Nomega-homocysteinyl-aminohexyl-Agarose
Joanna Perła, Anetta Undas, Tomasz Twardowski, et al.
Journal of Thrombosis and Thrombolysis
|
October 23, 2012
Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
Maciej Bochenek, Jaroslaw Zalewski, Jerzy Sadowski, et al.
Thrombosis Research
|
June 20, 2024
Altered fibrin clot phenotype in young adults with intracerebral hemorrhage of unknown cause: A case-control study
Paweł Łopatka, Michał Błaż, Grzegorz Nowicki, et al.
Cardiovascular Research
|
January 20, 2023
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
Michał Ząbczyk, Robert A S Ariëns, Anetta Undas
Thrombosis Research
|
January 1, 2013
Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation
Katarzyna Gronostaj, Piotr Richter, Wojciech Nowak, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
August 28, 2007
[Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus]
Agnieszka Padjas, Anetta Undas, Jakub Swadzba, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
September 10, 2014
Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients
Urszula Czubek, Tadeusz Góralczyk, Jarosław Zalewski, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 18, 2014
False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome
Tadeusz Góralczyk, Teresa Iwaniec, Ewa Wypasek, et al.
Page
of 66
Search research articles
Search
Showing results (171-180 of 652) with videos related to
Sort By:
Page
of 66
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
May 8, 2010
Shorter preoperative fibrin clot lysis time predisposes to higher chest tube drainage in patients undergoing elective coronary artery bypass grafting surgery
Anetta Undas, Ewa Wypasek, Bogusław Kapelak, et al.
Cardiovascular Diabetology
|
May 1, 2015
Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
Grzegorz Gajos, Malgorzata Konieczynska, Jaroslaw Zalewski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 19, 2004
Purification of antibodies against N-homocysteinylated proteins by affinity chromatography on Nomega-homocysteinyl-aminohexyl-Agarose
Joanna Perła, Anetta Undas, Tomasz Twardowski, et al.
Journal of Thrombosis and Thrombolysis
|
October 23, 2012
Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
Maciej Bochenek, Jaroslaw Zalewski, Jerzy Sadowski, et al.
Thrombosis Research
|
June 20, 2024
Altered fibrin clot phenotype in young adults with intracerebral hemorrhage of unknown cause: A case-control study
Paweł Łopatka, Michał Błaż, Grzegorz Nowicki, et al.
Cardiovascular Research
|
January 20, 2023
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
Michał Ząbczyk, Robert A S Ariëns, Anetta Undas
Thrombosis Research
|
January 1, 2013
Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation
Katarzyna Gronostaj, Piotr Richter, Wojciech Nowak, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
August 28, 2007
[Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus]
Agnieszka Padjas, Anetta Undas, Jakub Swadzba, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
September 10, 2014
Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients
Urszula Czubek, Tadeusz Góralczyk, Jarosław Zalewski, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 18, 2014
False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome
Tadeusz Góralczyk, Teresa Iwaniec, Ewa Wypasek, et al.
Page
of 66